Classement en actions
#21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Prix de l'action
$3.58
Dernière synchronisation: 2023-12-15
Capitalisation boursière
$101.57M
Changement (1 jour)
3.79%
Échange MDxHealth S.A. (MDXH)
Le prix MDXH avec la capitalisation boursière de B
Capitalisation boursière de MDxHealth S.A.(MDXH)
Capitalisation boursière: $101.57M
En August 2026, MDxHealth S.A. a une capitalisation boursière de $101.57M. Cela fait de MDxHealth S.A. la 21732nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de MDxHealth S.A. du 2006 au 2026
MDXH par rapport au top 5 des plus populaires stocks
| Prix pour MDXH |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.211T
|
+5,130,713.72%
|
|
|
|
|
$4.547T
|
+4,476,364.28%
|
|
|
|
|
$4.162T
|
+4,098,034.15%
|
|
|
|
|
$3.593T
|
+3,537,154.86%
|
|
|
|
|
$2.793T
|
+2,749,583.54%
|
